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Intersectin-1s (ITSN-1s), a protein containing ﬁve SH3 (A-E) domains, regulates via the SH3A the function of dynamin-2 (dyn2)
at the endocytic site. ITSN-1s expression was modulated in mouse lung endothelium by liposome delivery of either a plasmid
cDNA encoding myc-SH3A or a speciﬁc siRNA targeting ITSN-1 gene. The lung vasculature of SH3A-transduced and ITSN-1s-
deﬁcient mice was perfused with gold albumin (Au-BSA) to analyze by electron microscopy the morphological intermediates and
pathways involved in transendothelial transport or with dinitrophenylated (DNP)-BSA to quantify by ELISA its transport. Acute
modulation of ITSN-1s expression decreased the number of caveolae, impaired their transport, and opened the interendothelial
junctions, while upregulating compensatory nonconventional endocytic/transcytotic structures. Chronic inhibition of ITSN-1s
further increased the occurrence of nonconventional intermediates and partially restored the junctional integrity. These ﬁndings
indicate that ITSN-1s expression is required for caveolae function and eﬃcient transendothelial transport. Moreover, our results
demonstrate that ECs are highly adapted to perform their transport function while maintaining lung homeostasis.
1.Introduction
ITSN-1s is a multimodular protein, evolutionary conserved
and widely expressed [1, 2]; it consists of two NH2-termi-
Anal EH domains, a central coiled-coil domain, and ﬁve
consecutive COOH-terminal SH3 domains, SH3A-E, [3, 4].
Similarly to Dyn, ITSN-1s localizes to endocytic clathrin-
coated pits and caveolae at the plasma membrane and asso-
ciates preferentially with the neck region of caveolae [5, 6].
The simultaneous presence of multiple SH3 and EH do-
mains, best known for their function in endocytosis, as
well as the subcellular localization of ITSN-1s, led to the
early assumption that ITSN-1s may function as an adap-
tor/scaﬀold of the general endocytic machinery [3, 5]. Sub-
sequent studies have shown that ITSN-1s is capable of bind-
ing essential endocytic proteins, Epsin1/2, Eps15 [7], both
the neuronal and ubiquitously expressed Dyn isoforms,
[3,5,6,8],stonin2[9,10],andthesignalingproteinsRaIBP-
associated Eps15-homology domain protein [11], mSos [12,
13], and 5-phosphatase SHIP2 [14]. ITSN-1s binds several
Dyn molecules simultaneously and clusters them at the
endocytic sites, creating a high concentration of Dyn re-
quired for collar formation around the necks of endocytic
vesicles [6, 8]. This is a crucial endocytic event since the
GTPase activity of Dyn is allosterically dependent on Dyn
protein concentration [15, 16] and GTP-dependent self-
assembly of Dyn into rings around the necks of budding
v e s i c l e sp l a y sak eyr o l ei nm e m b ra n eﬁ s s i o n[ 17, 18]. Protein
overexpression, loss-of-function mutations, knockdown or
knockout approaches have provided compelling evidence
for the crucial role of ITSN-1s in scaﬀolding the general
endocytic machinery, recruitment of Dyn, and regulation of2 Biochemistry Research International
its function at the endocytic sites [6, 8, 16, 19–21]. Evidence
for a possible role of ITSN-1s in regulation of Dyn function
duringsynapticvesiclesendocytosishasbeenreportedindif-
ferent species and experimental conditions [16, 21–23]. The
ortholog of mammalian ITSN-1s in Caenorhabditis elegans
has a negative regulatory eﬀect on a Dyn-controlled pathway
or on Dyn itself [22]. Drosophila’s ITSN, Dyn-associated
protein (Dap160), scaﬀolds endocytic machinery and pro-
motes eﬃcient endocytosis by maintaining a high concentra-
tion of Dyn and allowing allosteric activation of its GTPase
activity at synapses [15, 16, 23]. Moreover, in lamprey giant
reticulospinal synapse, acute perturbation of ITSN-Dyn in-
teraction suggested that ITSN may control the amount of
Dyn released from the synaptic vesicle cluster to the periac-
tive zone and that ITSN may regulate ﬁssion of clathrin-
coated intermediates [21]. ITSN-1s knockout mice estab-
lished the requirement of ITSN-1s for eﬃcient synaptic
vesicle endocytosis and traﬃcking [20]. Moreover, the SH3A
domain of ITSN-1s has the unique ability to regulate Dyn2
oligomerization and its GTPase activity at the neck region
of caveolae [8]. Overexpression of full-length or truncated
ITSN-1s in cultured ECs caused severe impairment of cav-
eolae endocytic function. Electron microscopy analysis of
these cells revealed a wide range of morphological changes
such as caveolae with pleomorphic necks, many of them sur-
rounded by Dyn collars, caveolae clustering, and impaired
membrane ﬁssion [6, 8]. In particular, expression of the SH3
region, assumed to function in a dominant negative manner
by sequestering Dyn away from the caveolae endocytic sites
caused signiﬁcant decrease in caveolae number [6]. Recent
studies revealedthe association of ITSN-1 with arfaptin2, Src
homology 3 domain Growth factor receptor-bound 2-like
(endophilin) Interacting Protein 1 (SGIP1), and Fer/Cip4
homologydomainonlyproteins1and2(FCHO)withmem-
brane-deforming/bending activity essential for initiating
clathrin-coated pits maturation and coated vesicle formation
[11, 24, 25].
In the present study, we addressed the in vivo role of
ITSN-1s in the regulation of caveolae function in transendo-
thelial transport by experimental modulation of ITSN-1s
expressioninmouselungendothelium.Ourﬁndingsprovide
evidence that ITSN-1s is required for eﬃcient caveolae func-
tioning during transendothelial transport. Moreover, mod-
ulation of ITSN-1s expression and the subsequent impair-
ment of caveolae internalization and traﬃcking upregulated
alternative endocytic/transcytotic pathways to compensate
for deﬁcient caveolae function.
2.MaterialsandMethods
2.1. Materials. Cholesterol and dimethyl dioctadecyl ammo-
nium bromide (DDAB) and bovine serum albumin (BSA)
were from Sigma (St. Louis, MO). MicroBCA protein assay
kit and enhanced chemiluminescent substrate (ECL) were
from Pierce (Rockfort, IL). Relevant antibodies (Abs) were
purchased as follows: rabbit anti-DNP polyclonal Ab from
Invitrogen (Carlsbad, CA), ITSN-1 mAb from BD Transduc-
tion Laboratories (Lexington, KY), α-actin monoclonal Ab
from Sigma, and myc mAb from Cell Signaling (Danvers,
MA). SureBlue Reserve TMB Microwell Peroxidase Substrate
and horseradish-peroxidase- (HRP-) conjugated reporters
were from KPL (Gaithersburg MA). HyBlot CL ﬁlms were
from Denville Scientiﬁc Inc., (Metuchen, NJ). All electron
microscopy reagents were from Electron Microscopy Science
(Forth Washington, PA). The tracers, DNP-BSA, and 8nm-
BSAcomplexeswerepreparedinourlaboratoryaspreviously
described [26, 27]. Full-length human ITSN-1 cDNA (Gift
from Suzana de la Luna, Center for Genomic Regulation,
UPF, and Centro de Investigacion Biomedica en Red de
Enfermedades Raras (CIBERER-ISCIII), Barcelona, Spain),
wasusedasatemplatetogenerateC-terminalmyc-his-SH3A
(residues 740–806) as in [8]. SMARTpool reagents and
ITSN-1 siRNA duplex [GGACAUAGUUGUACUGAAAUU
(sense sequence) and 5 -UUUCAGUACAACUAUGU CCUU
(antisense sequence)] for knocking down ITSN-1s expres-
sion were from Dharmacon (Lafayette, CO).
2.2.Animals. CD1malemice,6–8weeksold,20–25gweight,
from Jackson Laboratory (Bar Harbor, ME), kept under
standardized housing and feeding conditions, were used.
The experiments were done under anesthesia, using keta-
mine (60mg/kg), acepromazine + xylasine (2.5mg/kg) +
(2.5mg/kg), and xylazine (2.5mg/kg) in 0.1-0.2mL PBS. All
experiments were approved and performed in accordance
with the guidelines of Rush University Institutional Animal
Care and Use Committee.
2.3. Protein Extraction. Mouse lung tissue was homogenized
in a buﬀer containing 150mMNaCl, 50mM Tris, pH 8.0
andprotease inhibitors; total lysateswereprepared byadding
NP-40, to a ﬁnal concentration of 1.0%, for 2h, at 4◦C. The
resulted lysates were clariﬁed by centrifugation in a Beckman
tabletop ultracentrifuge with a TLA-55 rotor, for 45min, at
4◦C and 45,000rpm. Protein concentration was determined
by the microBCA method with a BSA standard.
2.4. Western Blot and Densitometry. Equal amounts of total
protein (70μg/lane) were subjected to 4–20% SDS PAGE,
transferred to nitrocellulose membranes, and then subjected
toWesternblotanalysesasin[28],usingAbsagainstITSN-1s,
myc tag, as well as actin as loading control. The bands of im-
munoreactivity were visualized using an appropriate HRP-
conjugated reporter Ab and ECL detection. HyBlot CL
ﬁlms were subjected to densitometric analysis using NIH
ImageJ1.37v software.
2.5. Cationic-Liposome-Mediated Delivery of Myc-SH3A and
ITSN-1s siRNA to Mouse Lungs. Cationic liposomes were
prepared using DDAB and cholesterol by rotary evaporation
of lipid solutions in chloroform, at 42◦C, under vacuum as
in [29, 30]. The lipid ﬁlm was rehydrated for 1h at RT in 5%
dextrose followed by sonication and sterile ﬁltration through
0.47μm and 0.22μm membranes. Then, the suspension was
extruded through a 50nm polycarbonate ﬁlter mounted
on a miniextruder device (Avestin, Inc., ON, Canada), to
assure unilamellar vesicles formation. DNA-liposomes com-
plexes were prepared using ratio 8 nmoles liposomes: 1μgBiochemistry Research International 3
myc-SH3A DNA. For silencing ITSN-1 gene expression in
mouse lungs we used Dharmacon SMARTpool reagents,
as in [19]. RNase free conditions and reagents were used
throughout the silencing experiments. Preliminary experi-
ments were performed to identify the siRNA sequence of the
SMARTpool, most eﬃcient in silencing ITSN-1s gene. Brief-
ly, the siRNA sequences for knocking down ITSN-1s protein
expression were ﬁrst delivered in cultured mouse ﬁbrob-
lasts using Dharmafect Transfection Reagent according to
the manufacturer’s instructions. The target sequence 5 -
GAGAGAGCCAAGCCG GAAA-3  was found to be the most
eﬃcient in downregulation of ITSN-1s expression in mouse
ﬁbroblastsandthus,usedtogeneratethesiRNAduplexforin
vivo delivery. Also, the siCONTROL functional nontargeting
siRNA sequence 5 -UAGCGACUAAACACAUCAA-3  was
used as a control for potential secondary eﬀects caused by
siRNA transfection of mouse ﬁbroblasts.
For silencing ITSN-1s gene, siRNA/liposomes complexes
we prepared using 100μg ITSN-1s/mouse, 1:3 (vol/vol)
siRNA:liposomes ratio. Mice were injected intravenously
(tail vein) with cationic liposomes complexes, to achieve
either transduction of the speciﬁc myc-SH3A construct or
knockdown of ITSN-1s in lung microvessels. The lungs were
collected at diﬀerent time points after the ﬁrst delivery of
myc-SH3A plasmid or ITSN-1s siRNA/liposomes complexes
to monitor myc-SH3A and ITSN-1s protein expression
levels.
2.6. DNP-BSA and 8nm Au-BSA Perfusion. DNP-BSA
(10mg/mL) was perfused as in [26], to assess lung vascular
permeability to albumin in control mice, mice expressing the
SH3A, or ITSN-1s-deﬁcient mice. The biochemical quanti-
ﬁcation of transendothelial transport was done as in [26].
Brieﬂy, after tracer perfusion, the lungs were hand minced
and homogenized in PBS, using a Brinkmann poly-
tron (1min, 4◦C). The homogenates were centrifuged
(45,000rpm, 45min) to obtain the ﬁnal supernatants, ex-
pected to contain the lung interstitial ﬂuid and thus, the
DNP-derivatized BSA transported to the lung interstitia. The
amounts of DNP-BSA were assessed by ELISA using HRP-
conjugated anti-DNP Ab followed by a colorimetric assay
with TMB microwell peroxidase substrate as in [26]. The
plates were read in an ELISA reader at 650nm. For quan-
titative assessment of DNP-BSA transendothelial transport,
a standard curve using known concentration of DNP-BSA
was generated. The data were expressed in ng DNP-BSA nor-
malized per mg total protein and 10min. Au-BSA complexes
(A520 = 1.0) were perfused in situ for 10min, the unbound
tracer was ﬂushed out by 3min perfusion using oxygenated
PBS as in [27].
2.7. RT-PCR. Mouse lung total RNA was extracted using
RNeasyMiniKitwithon-columnDNasedigestionbyRNase-
free DNase set (Qiagen, Valencia, CA). The cDNA was syn-
thesized by using the High-Capacity Reverse Transcription
Kits (Applied Biosystems, ABI, Carlsbad, CA). The RT-PCR
reactions were ampliﬁed for 35 cycles with the appropriate
primer sets for the target genes, mouse ITSN-1s, ITSN-2s
and ITSN-2L, and a house-keeping gene cyclophilin by using
GoTag Green Master Mix (Promega, San Luis Obispo, CA).
T woto10μLofPCRproductsweresubjectedto1.2%agarose
gel electrophoresis and visualized using an Alpha Innotech
AlphaImagerIIsystem.Primerpairs(Sigma,SanLouis,MO)
used in PCR: mouse ITSN-1s (forward: 5 -CAGGCT-
TGAAAAGTCCTCAAA-3 ,r e v e r s e :5  -GGTGATCATGCT-
GGAAGTCA-3 ); mouse ITSN-2s (forward: 5 -CTGGGC-
ACAATGCAGCCTACG-3 ,r e v e r s e :5  -CAAAAAGTTGCA-
GGCCGTCCATG-3 ), mouse ITSN-2L (forward: 5 -CCA-
GGACGTTCTGTGTCTCACTATG-3 ,r e v e r s e :5  -CAG-
TAGTAGTCGGCGGGTGGT-3 ), and mouse Cyclophilin
(forward: 5 -GGCAAATGCTGGACCAAACAC-3 , reverse:
5 -TTCCTGGACCCAAAACGCTC-3 ).
2.8. Real-Time qPCR. r e acti o n sw e r epe rf o rm edu s i n gP o w e r
SYBR Green PCR Master Mix (ABI) and analyzed in trip-
licate with a MyiQ Single Color Real-Time PCR Detection
System(Bio-Rad,Hercules,CA).Therelativeexpressionlevel
foreachgenewascalculatedbyamathematicaldelta-deltaCt
method developed by Applied Biosystems. The amounts of
RNA were normalized to the house-keeping gene cyclophilin
for all time points and reported relative to control mouse
lungs (set at 1).
2.9. Electron Microscopy. 8nm Au-BSA perfused mouse
lungswereﬁxedinsituby15minwith4%(wt/vol)formalde-
hydeand2.5%glutaraldehydein1%tannicacidin0.1PIPES
buﬀer pH 7.2, and then excised and ﬁxed for 1h at RT, in the
same ﬁxative mixture. Fixed lungs were used to collect small
tissue blocks that were processed for electron microscopy by
standard procedures including 4% OsO4 alter ﬁxation as in
[26, 27]. Selected specimens were dehydrated in increasing
concentrations of ethanol, followed by propylene oxide, and
embedded in Epon 812. Thin sections cut from blocks were
mounted on nickel grids, then stained with uranyl acetate
and lead citrate, and ﬁnally examined and micrographed in a
Joel 1220 transmission electron microscope.
2.10. Morphometric Analyses. Morphometric analyses of
normal and altered caveolar proﬁles as well as nonconven-
tional endocytic/transcytotic structures were performed as
described previously [6]. Brieﬂy, 15–20 sections per grid
and 3–5 grids per block, from 8 Epon812 blocks, chosen at
random from control and ITSN-1s siRNA-treated mice, were
used. The morphological appearance was recorded on 150
micrographs (×30,000 standard magniﬁcation) for each ex-
perimental condition. The measurement of the length plas-
ma membrane on the electron micrograph used was per-
formed as in [31] .T h ed a t aw e r en o r m a l i z e dp e r1 0 0 μm
length plasma membrane and are averages ± SD of three
independent experiments.
2.11. Statistical Analysis. Data were compared using one way
analysis of variance, Student’s t-test with a Bonferoni cor-
rection for multiple comparisons, and a two-way analysis
of variance where needed. Statistical signiﬁcance was set at
P<0.05.4 Biochemistry Research International
3. Results
3.1. Experimental Manipulation of ITSN-1s Expression in
Mouse Lungs. To evaluate in vivo the role of ITSN-1s in reg-
ulating caveolae function during transendothelial transport
we modulated the expression of ITSN-1s in mouse lung en-
dotheliumbyliposomedeliveryofaplasmidcDNAencoding
the SH3A domain, or a speciﬁc siRNA duplex targeting
ITSN-1 gene. Myc-SH3A DNA plasmid:liposomes com-
plexes, prepared as described under Materials and Methods,
were delivered intravenously to mouse lungs as in [29, 30].
The lungs were collected at diﬀerent time points after the
ﬁrst delivery of myc-SH3A lipoplexes to monitor myc-SH3A
protein expression. Western blot of mouse lung lysates using
myc mAb indicated eﬃcient SH3A expression, at 48h alter
DNA treatment (Figure 1(a)). For ITSN-1s knockdown, the
silencing eﬀect of ITSN-1s siRNA started at 48h, it was
obvious at 72h alter siRNA administration and lasted for an
additional 72h, as evaluated by Western blot of mouse lung
lysates with ITSN-1 mAb (Figure 1(b)). ITSN-1s protein ex-
pression recovered at 168h alter siRNA delivery. Actin was
used as a loading control. ITSN-1s knockdown did not aﬀect
the expression of caveolin-1 (Cav1), the structural protein
of caveolae coat [32]. Densitometric analyses indicated a
greater than 70% reduction of ITSN-1s protein levels at day
3, compared to wild-type untreated mice (Figure 1(c), aster-
isk). Intravenous injection of empty liposomes did not aﬀect
ITSN-1s protein levels (not shown). Eﬃcient knockdown
of ITSN-1s at 72h following siRNA delivery was further
conﬁrmed by real-time quantitative (q) PCR (Figure 1(d)).
ITSN-1s mRNA levels in ITSN-1s siRNA-treated mouse lung
samples were more than 3-fold lower by reference to controls
(Figure 1(d),asterisk).Deliveryofemptyliposomes(vehicle)
did not aﬀect the levels of mRNA in mouse lungs, compared
to untreated mice. To get more insights into the eﬀects of
ITSN-1s deﬁciency on caveolae function we also generated a
mouse model with chronic inhibition of ITSN-1s, by repeat-
ed delivery of ITSN-1s siRNA/liposome complexes, every
72hr, for 24 consecutive days (Figure 1(e)). Western blot
analyses applied on mouse lung lysates of ITSN-1s siRNA-
treated indicated continuous knockdown of ITSN-1s for 21
days. For accurate quantitative data, we used again qPCR
analysis. The results indicated that the real knockdown of the
target ITSN-1 gene was about 3-fold by reference to cyclo-
philin, the gene used as standard (Figure 1(d),d o u b l ea s -
terisk). In addition, conventional RT PCR applied on lung
samples prepared from controls and ITSN-1s-deﬁcient mice
(Figure 1(f)) demonstrated that the knockdown of ITSN-1s
is speciﬁc and eﬃcient. The expression of ITSN-1s mRNA
was not detected at days 10, 15 and 24 alter ITSN-1s siRNA
delivery, while ITSN-2s and ITSN-2L mRNAs were not
detectably aﬀected by comparison to untreated controls.
These murine models generated by liposome delivery of the
cDNA plasmid encoding the SH3A domain and the ITSN-
1s siRNA were used for a further in-detail study of ITSN-1s
endocytic function.
3.2. Acute Perturbation of ITSN-1s Expression Induces Ple-
omorphic Endocytic/Transcytotic Structures and Increases
Mouse Lung Vascular Permeability. Once eﬃcient expression
of myc-SH3A was achieved, (48h alter administration of
myc-SH3A plasmid/liposome complexes), DNP-BSA was
perfusedthroughmouselungmicrovasculatureanditstrans-
endothelial transport was quantiﬁed by ELISA, as in [26].
The expression of the SH3A in mouse lung endothelium
caused greater than 36% increase in transendothelial trans-
port of DNP-BSA, compared to controls (Figure 2(a)), sug-
gesting disruption of the interendothelial junctions (IEJs).
The opening of IEJs was further conﬁrmed by perfusion of
8nm Au-BSA, at 48h alter myc-SH3A administration. Elec-
tron microscopy analysis of the transport pathway followed
by 8nm Au-BSA from the lumen to the perivascular space
in control specimens indicated nearly exclusive association
between the tracer and caveolae (Figure 2(b)). After 10min
perfusion, we detected the tracer in the vessel lumen, (Figure
2(b), t), in vesicles open to the luminal side of ECs (Figure
2(b), v1), in vesicles within the endothelial cytoplasm, pre-
sumably in transit across the endothelium, (Figure 2(b),v 2 ) ,
in vesicles discharging their load in the perivascular space
(Figure 2(b), v3), and in variable number in the perivascular
space (not shown). We also determined the location of the
tracerinrelationtoIEJs.Wefoundnotracerinthejunctional
proﬁles or associated with their abluminal exit; IEJs were not
permeatedbythetracerparticlesthat,generatedhowever,ﬁl-
tration residues in their luminal introit, (Figure 2(b),a r r o w -
head). On the contrary, the transendothelial transport of
tracer particles in mouse lung endothelium expressing the
SH3A revealed open IEJs permeated by Au-BSA complexes
(Figures 2(c),a n d2(c1), arrows) and in some cases, heavy
association of gold particles with the abluminal exit of IEJs
(Figures 2(c),a n d2(c2)). Interestingly, in SH3A-expressing
mouse specimens, caveolae (Figures 2(c), 2(c3), and 2(c4),
arrows) and clathrin-coated pits (Figures 2(c), 2(c7), arrow)
with long necks, and caveolae whose narrow necks were sur-
rounded by staining-dense collars (Figures 2(c), 2(c5), 2(c6),
arrows) were frequently observed. A clathrin-coated pit with
elongated neck is shown in Figures 2(c), 2(c8) (boxed area,
inset). In addition to caveolae, a large number of elongated
elements and tubular membranous structures, many of them
labeledbygoldparticles(Figures2(c),2(c1),and2(c9)(black
boxed structures), and insets c9.1, c9.2) comprising caveolae
and coated pits (Figures 2(c), 2(c9), and 2(c10), white boxed
structures) as well as large and uncharacteristic caveolae
clusters (c10, arrow and inset c10.1) occupied the intracellu-
lar space, in close proximity of the plasma membrane. The
diameter of the tubules ranged between 25nm to 60nm,
while their length varied between 150nm to 600nm (n = 70
tubules). As previously shown by us [33], the tubular ele-
ments may be part of an endosomal tubulovesicular network
that may communicate with cell surface via caveolae and
clathrin-coated vesicles. The network may be upregulated by
expression of the SH3A and acute disturbance of ITSN-1s/
Dyn2 interaction. The observation also reﬂects impaired
membrane ﬁssion reaction and thus, a stimulatory eﬀect of
impaired Dyn2 function on growth of dynamic tubular
structures as reported for cells lacking Dyn1/Dyn2 [34].
Delivery of empty liposomes did not aﬀect the morphology
of caveolae or ECs (not shown). Based on these ﬁndings weBiochemistry Research International 5
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Figure 1: Experimental modulation of ITSN-1 expression in mouse lungs. (a) Myc-SH3A domain of ITSN-1s is eﬃciently expressed in
mouse lungs, at 48h alter delivery of the plasmid cDNA/liposome complexes. Mouse lung lysates (70μg total protein/lane) of control and
myc-SH3A-transduced mice were subjected to 4–20% SDS PAGE, transferred to nitrocellulose membrane and immunoblotted with myc
Ab. (b) siRNA-mediated knockdown of ITSN-1s in mouse lungs. Lung lysates (70μg total protein/lane) of controls and mice injected with
liposomes/ITSN-1s siRNA complexes were resolved on 4–20% SDS PAGE and the electrophoretograms were transferred to nitrocellulose
membrane followed by Western blot with Abs against ITSN-1, actin (as a loading control) and cav-1. Note the eﬃcient knockdown of ITSN-
1s protein for 96h, starting at day 3 (3d) alter siRNA delivery. (c) Densitometric analysis of representative HyBlot CL ﬁlms demonstrates
that treatment with ITSN-1s siRNA/liposome complexes downregulates eﬃciently ITSN-1s protein in mouse lungs. (d) Quantitative RT
PCR of ITSN-1s mRNA in ITSN-1s siRNA treated mouse lungs. Values were normalized to the house-keeping gene cyclophilin and reported
relative to control lungs (set at 1). (e) Chronic inhibition of ITSN-1s expression for 21 consecutive days by repeated delivery of ITSN-1s
siRNA/liposomescomplexes.LunglysatesofcontrolandITSN-1s-siRNA-treatedmicewereanalyzedbyWesternblotwithAbsagainstITSN-
1s and actin, as loading control, at several time points alter delivery, as indicated. (f) Conventional RT-PCR of ITSNs isoforms expressed
in mouse lungs. RT PCR reactions were ampliﬁed as described under Materials and Methods using appropriate primer sets for the target
genes, ITSN-1s, ITSN-2s and ITSN-2L, and a house-keeping gene cyclophilin. 5-μLo fP C Rp r o d u c t sw e r es u b j e c t e dt o1 . 2 %a g a r o s eg e l
electrophoresis and visualized using an Alpha Innotech AlphaImager II system. All data shown are representative for 3 diﬀerent experiments,
(3 mice/experimental condition).6 Biochemistry Research International
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Figure 2: Increased endothelial permeability, impaired membrane ﬁssion, and increased occurrence of nonconventional endocytic/
transcytotic intermediates in the mouse lungs expressing the SH3A domain of ITSN-1s. (a) ELISA applied on mouse lung lysates of control,
empty liposomes, and myc-SH3A-transduced mice perfused with 10mg/mL BSA-DNP, for 10min. Results were expressed in ng BSA-DNP/
mg total protein/10min. Bars ± SD. Results were obtained in 4-5 diﬀerent experiments, with three mice per experimental condition. (b)
RepresentativeEMimageshowingthetransendothelialtransportof8nmAu-BSAincontrolmouselung.Tracerparticlesweredetectedinthe
vessellumen,(t),invesiclesopentotheluminalsideofECs(v1),invesicleswithintheendothelialcytoplasm,(v2),andinvesiclesdischarging
their load in the perivascular space (pvs; v3). Tracer particles did not permeate the IEJ and generated ﬁltration residues (arrowhead), in the
luminal introit of the junction. Scale bar: 100nm. (c) Representative electron micrographs showing transendothelial transport of 8nm
Au-BSA in SH3A-transduced mouse lung specimens as well as nonconventional endocytic/transcytotic intermediates in ECs expressing the
SH3A domain of ITSN-1. Open IEJ permeated by 8nm gold BSA complexes (c1) and heavy association of gold particles with the abluminal
exit of an IEJ (c2). Caveolae (c3, c4, arrows) and clathrin-coated pits (c7, arrow) with very long necks, and caveolae with their narrow necks
surrounded by staining-dense collars (c5, c6 arrowheads) were frequently observed. A clathrin-coated pit with elongated neck is shown (c8,
boxed area, inset). Elongated elements and tubular membranous structures, labeled by gold particles (c1, c9, black boxed structures, c9.1,
a9.2) and comprising caveolae and coated pits (c9, c10, white boxed structures) as well as large and uncharacteristic caveolae clusters (c10,
arrow and inset). Bars: 200nm—(c1), (c3), (c7), (c8), (c9.1); 100nm—(c2), (c4), (c6), (c9), (c8) inset, (c10); 50nm—(c5), (c9.2).Biochemistry Research International 7
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Figure 3:Increasedendothelialpermeabilityandimpairedinterendothelialjunctionalintegrityinmouselungendotheliumacutelydepleted
of ITSN-1s. (a) ELISA applied on mouse lung lysates of control, empty liposomes, and ITSN-1s siRNA-treated mice, (72h alter siRNA),
perfused with 10mg/mL BSA-DNP, for 10min. Results were obtained in 4-5 diﬀerent experiments, (3 mice/experimental condition), and
expressed in ng BSA-DNP/mg total protein/10min. Bars ± SD. (b, c) EM morphology of IEJs in control (b) and ITSN-1s siRNA (c) mouse
lung endothelium. Arrows in B point to the dense protein matrix of the tight junctions sealing the interendothelial space. Arrowheads in (c)
point to three open IEJs. EC: endothelial cell; m: mitochondria. Bar: 150nm. (d, e) Representative electron micrographs showing open IEJs
labeled throughout their length by 8nm Au-BSA particles. Arrows in (d) and magniﬁed d1, point to three-four Au-BSA particles located
close to each other in the same plan, indicative of the wide opening of the IEJ. Gold particles are also associated with the abluminal exit of
IEJs. Note also the limited number of caveolae and dilation of the pericapillary space (pcs; asterisks). Bars: 200nm (d); 100nm (e).
concluded that in the presence of SH3A, similar to cultured
ECs [8], Dyn2/Dyn2 interactions are stabilized, Dyn2 func-
tion is impaired and caveolae cannot detach from the plasma
membrane to form free transport vesicles. Thus, impaired
caveolae function triggered the expansion of dynamic tubu-
lar structures to compensate for deﬁcient transport via
caveolae.
Next, the functional eﬀects of acute ITSN-1s deﬁciency
(72h) on lung microvascular permeability were assessed
by 10min perfusion of 10mg/mL DNP-BSA through
mouse lung microvasculature and quantifying by ELISA the
amounts of DNP-BSA tracer transported to lung interstitia,
as above. We observed a signiﬁcant increase in DNP-BSA
transport in the ITSN-1s-deﬁcient mouse relative to controls
(i.e., 472ng DNP-BSA/mg total protein/10min in knock-
down mouse versus 328.3ng DNP-BSA/mg total protein/
10min, in controls), consistent with endothelial barrier dys-
function,Figure 3(a).Wefurtheranalyzedbyelectronmicro-
scopythemorphologyofIEJsandifthetracer,8nmAu-BSA,
can escape through open IEJs. Detailed analysis of ultrathin
sections prepared from randomly chosen mouse lung spec-
imens acutely depleted of ITSN-1s showed frequently open8 Biochemistry Research International
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Figure 4: Acute perturbation of ITSN-1s expression induces pleomorphic endocytic/transcytotic intermediates. (a–f) Representative EM
images of membranous rings (a, a1, e, e.1, f), tubular elements (b, c, d, arrows) and enlarged endosomes (d, arrowheads), loaded with 8nm
Au-BSA and associated with caveolae-like morphology. Two tubular structures open to the lumen are shown in (c) and (e). The EM image
shown in (e) was selected from a mouse lung specimen not perfused with 8nm Au-BSA. Note also the severe dilation of the perivascular
space (pvs) and the proteinaceous edema (a). Bars: 250nm (a, b); 200nm (c, d); 150nm (f); 100nm (a1, e).
IEJs. The electron micrograph in Figure 3(c) shows a tri-
cellular junction where one side is obviously open. For the
IEJs between the EC2 and EC3, the sectioning of the tissue is
less favorable and one cannot conclude on junctional restric-
tiveness. By contrast, in control specimens (Figure 3(b)) the
interendothelial space is sealed by the tight junctions, which
are the most apical IEJ structures (Figure 3(b), arrows).
These observations strongly demonstrated that the increased
permeability for BSA-DNP in the lung vasculature of ITSN-
1s-deﬁcient mouse is due, similar to the SH3A expressing
mice, to the frequent presence of open IEJs. In ITSN-1s de-
pleted specimens, perfused with 8nm Au-BSA, the pattern
ofvesicularlabeling wassimilartocontrols,(Figure 2(b)).By
distinction to controls, we detected open IEJs heavily labeled
throughout their length by Au-BSA particles. Morphometric
analysis indicated that about 48% of IEJs counted were open
andpenetratedby8nmAu-BSAcomplexes(n = 227).Under
controlconditions,mainlyinpostcapillaryvenules,wefound
that approximately 30% of junctions were open to ∼6nm,
thus allowing water, ions, and small molecules to take the
paracellular pathway to the interstitia, data that are in agree-
ment with [35]. Given the size of Au-BSA complexes (the
overall diameter of Au-BSA complexes (gold + BSA mol-
ecules) is about 20nm), we can estimate that the junctions
werewidelyopen:if,forexample,insomeareas,threeorfour
gold particles are found in the same horizontal plan, labeling
the junctional space, the opening of the junction could be
estimated at about 60nm–80nm width. We also detected
gold particles associated with the abluminal exit of the junc-
tion (Figures 3(d), 3(d1), and 3(e)). Extensive dilation of the
perivascular space and rich proteinaceous edema is another
phenotypiccharacteristicofthesemouselungs(Figures3(d),
and 4(a), asterisks). A new interesting observation was the
frequent detection of pleomorphic morphological struc-
tures/ intermediates thought to function in alternative endo-
cytic pathways, such as membranous rings (Figures 4(a),Biochemistry Research International 9
4(a1), 4(e), 4(e1), 4(f)), many of them heavily loaded with
8nm Au-BSA particles (Figures 4(a), and 4(a1)), tubules and
tubulovesicular elements open to the lumen (Figure 4(b),
boxed structures, 4(c), 4(e)) or with no noticeable commu-
nication with the extracellular environment (Figures 4(b),
4(c), 4(d), arrows), and enlarged endocytic structures, many
of them fused with typical caveolae, apparently discharging
their load (Figure 4(d), arrowheads). The rings ranged be-
tween 150nm and 400nm diameter (n = 65 rings) and dis-
p l a y e dan a r r o wl u m e n ,( 2 0n m± 4nm). Finally, signiﬁcant
decrease in caveolae number was also observed in mouse
lung ECs deﬁcient of ITSN-1 by reference to controls
(Table 1). The ﬁndings strongly suggested that ineﬃcient
Dyn2 recruitment to the endocytic site caused by ITSN-1s
deﬁciency, and the resultant impaired formation of free
caveolae able to function in the transendothelial transport,
caused not only disruption of the IEJs, but also prompted
the ECs of the mouse lung vasculature to upregulate and em-
ploy some alternative/compensatory pathways for endocytic
internalization and transendothelial transport (Table 1). Ac-
cumulation of tubular elements may also reﬂect the eﬀect of
ineﬃcient Dyn2 recruitment to the endocytic sites, as previ-
ously reported for cells lacking Dyn1/Dyn2 [34]. Alltogether,
the ﬁndings demonstrate that normal ITSN-1s expression
is crucial for Dyn-mediated membrane ﬁssion reaction of
caveolae, for maintaining the caveolae number and for their
transport function in lung microvascular ECs. Moreover,
experimental manipulation of ITSN-1s expression induces
alternative endocytic/transcytotic pathways.
3.3. Chronic Inhibition of ITSN-1s Expression Partially Re-
stores Caveolae Number and IEJ Integrity While Maintaining
the Activation of Alternative Endocytic/Transcytotic Pathways.
To get more insight into the role of ITSN-1s in regulation
of caveolae transport function and endothelial permeability
we next used the mouse model with chronic inhibition of
ITSN-1s expression for 21 consecutive days (Figure 1(c)).
The functional eﬀects of chronic ITSN-1s deﬁciency on lung
microvascular permeability were assessed by 10min perfu-
sion of DNP-BSA through mouse lung microvasculature and
quantifying by ELISA the amounts of DNP-BSA tracer trans-
ported to lung interstitia, as described above. The ﬁndings
were somehow intriguing; transendothelial transport of
DNP-BSA as quantiﬁed by ELISA, via DNP Ab returns to
c o n t r o ll e v e l s( Figure 5(a)).
The electron microscopy morphological assessment of
interendothelial junctional integrity in mice with chronic
inhibition of ITSN-1s expression indicated that the 8nm Au-
BSAparticles cannot penetratethe IEJs. Instead,theyformed
ﬁltration residues in the luminal introit of the junction
(Figures 5(b) and 5(d), arrows). Interestingly however, the
perivascular spaces showed some dilation and mild edema,
suggesting that the IEJs are still leaky, but not permeable to
the size of our tracer.
Another interesting observation was the frequent detec-
tion of multivesicular bodies (mvb), comprising internal
small vesicles of about 50nm diameter, some of them loaded
with 8nm Au BSA particles (Figures 5(c) and 5(d)). The
alternative endocytic pathways and their morphological in-
termediates are still present and better represented (Figure
6). Membranous rings with diameters between 100nm to
400nm,(Figures6(a)and6(c)),freeinthecytosoloropento
the lumen and tubules (Figures 6(b), 6(d), and 6(e)), some
of them branching or discharging tracer in the perivascular
space, (Figure 6(b), boxed structure, and inset), and en-
larged endocytic structures (most probably secondary lyso-
somes), many of them fused with typical caveolae (Figure
6(a), arrow) were frequently detected. Often, the tubular
structures connected to the plasma membrane displayed at
their cytosolic termini caveolae (Figures 6, 6(b1)) or coated
vesicles (Figure 6(e), arrowhead). We have also found mem-
brane ruﬄes (Figure 6(f), arrow, and insets (f.1), (f.2)) and
macropinocytic vesicles (Figure 6(f), mpv1, mpv2), involved
in tracer uptake, as shown by their gold labeling, and thus,
possibly compensating for deﬁcient caveolae transport.
Morphometric analyses indicated that the number of
endocytic/transcytotic structures is slightly increased at day
24, compared to 72h time point, with the membranous
ring/tubuleslabeledbyAu-BSAshowingafurtherincreaseto
14-fold, compared to controls (Table 1). Caveolae number is
partially restored, only 17.8% decrease, by reference to con-
trol conditions. Collectively, these observations emphasize
that physiological levels of ITSN-1s are critical for trans-
endothelial transport via caveolae and paracellular perme-
ability in vivo.
4. Discussion
We have shown that ITSN-1s is required for eﬃcient trans-
endothelialtransportviacaveolaeandprovidedinvivo ultra-
structural evidence to suggest that modulation of ITSN-1s
expression activates the paracellular pathway as well as a
previously described, but less understood endocytic tubu-
lovesicular network and membranous rings that seem to
eﬃciently compensate for deﬁcient caveolae transport func-
tion. So far, limited evidence regarding nonconventional
endocytic mechanisms were partly obtained in cultured cells
mainly by studies of toxins and viruses [36–40]. In this study,
using a murine model expressing the myc-SH3A domain of
ITSN-1s, capable of regulating Dyn2 activity at the endocytic
sites [8], and mice acutely (72h) and chronically (21d)
depleted of ITSN-1s via siRNA, we directly demonstrate that
by interfering with expression of ITSN-1s, a key partner of
Dyn in endocytic membrane ﬁssion, the caveolae function
was disrupted and alternative endocytic/transcytotic path-
ways and their morphological intermediates were activated.
Prior studies by others and us indicated that ITSN-1s
functionsbyrecruitingDynandregulatingitsfunctionatthe
endocytic site [6, 8, 16, 21–23, 41]. Studies in cultured ECs,
complementedbyinvitroassaysdemonstratedthattheSH3A
domain of ITSN-1s stimulates both basal and assembly-
stimulatedGTPaseactivityofDyn2,aswellasDyn2abilityto
form oligomeric structures [8]. In the presence of SH3A at
the endocytic site, Dyn2/Dyn2 interactions are stabilized, the
lifetime of assembled Dyn2 is prolonged, and despite contin-
uous GTP hydrolysis, Dyn2 oligomers cannot disassemble.
Membrane ﬁssion reaction and the subsequent detachment10 Biochemistry Research International
Table 1: Chronic inhibition of intersectin-1s expression causes the activation of alternative endocytic/transcytotic pathways and partially
restores caveolae number.
Endocytic/transcytotic structures Control ITSN-1s siRNA, 72h ITSN-1s siRNA, 24d
Caveolae open to the lumen∗ 106.6 ±9.55 0 .46 ±4.88 7 .15 ±5.9
Caveolae apparently free in the cytosol 173.5 ±12.07 7 .41 ±6.3 143.0 ±9.5
Total caveolae (luminal and free in the cytosol) 280.1 ±21.5 127.86 ±11.1 230.14 ±15.4
Abnormal endocytic structures (enlarged endosomes) 2.65 ± .34 11.29 ±2.71 4 .93 ±3.8
Caveolae clusters 3.95 ±.45 .64 ±1.61 1 .3 ±2.5
Membranous rings 1.33 ±.04 9.47 ±2.41 2 .8 ±2.8
Tubules .88 ±.05 4.0 ±1.31 8 .84 ±3.4
∗Results are normalized per 100μmE Cl e n g t h .
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Figure 5: Chronic inhibition of ITSN-1s expression partially restores caveolae number and IEJ integrity. (a) ELISA applied on mouse lung
lysates of control, empty liposomes, and ITSN-1s siRNA-treated mice, 24d alter delivery, perfused with 10mg/mL BSA-DNP, for 10min.
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Bars ± SD. (b, d) Filtration residues in the luminal introit of two IEJs (arrowheads). Mild dilation (∗) of the pvs suggests leakiness of the
IEJs. Multivesicular bodies (mvb), in close proximity of the plasma membrane, have some of their internal small vesicles, labeled by 8nm
Au-BSA particles (c, d). Bars: 100nm.
of caveolae from the plasma membrane leading to the
formation of free vesicular carriers were inhibited. Here, we
extended these studies and expressed the SH3A of ITSN-1s
in mouse lung endothelium, to address the in vivo regulatory
role of ITSN-1s on membrane ﬁssion and Dyn itself. Similar
to cultured cells, we see impaired caveolae release from the
plasma membrane, caveolae necks surrounded by staining-
dense collars as well as elongated elements and tubular
membranous structures, associated with caveolae-like mor-
phology. In addition, the deﬁcient transcellular transport via
caveolae caused opening of the IEJs and activation of the
paracellular pathway, consistent with a functional crosstalk
between the trans- and paracellular transport pathways in
mouse lung endothelium. These observations support the in
vivo role of ITSN-1s, via its SH3A domain, in regulation of
Dyn2 function at the neck of caveolae and the importanceBiochemistry Research International 11
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Figure 6: Chronic inhibition of ITSN-1s expression augments the activation of alternative endocytic/transcytotic pathways. (a–e) tubu-
lovesicular EM images of membranous rings with diameters between 100nm to 400nm, (a, c), free in the cytosol or open to the lumen
and tubules (b, d, e), some of them branching or discharging tracer in the perivascular space, (b, boxed structure, and inset), and enlarged
endocytic structures, many of them fused with typical caveolae (a). Note the tubular structures are connected to the plasma membrane
and displaying at their cytosolic termini caveolae (b1) or coated vesicles (e, arrowhead). Bars: 100nm (b, c, d); 250nm (a); 75nm (e); (f)
membrane ruﬄes (f, arrow, insets f.1, f.2) and large macropinocytic vesicles (mpv1, mpv2) labeled by tracer particles. Bar: 150nm.
of ITSN-1s/Dyn2 interaction in caveolae internalization and
traﬃcking.
AcutesiRNA-mediatedknockdownofITSN-1s,72halter
liposomes/siRNA delivery caused 59% decrease in caveolae
number, disruption of IEJs, leading to 43% increase in DNP-
BSAtransendothelial transport,comparedtocontrols.With-
out ITSN-1s, Dyn2 a major interacting partner of ITSN-1s
and essential player in detachment of caveolae from the plas-
mamembraneisnoteﬃcientlyrecruitedtotheendocyticsite
and thereby, caveolae detachment from the plasma mem-
brane and formation of free vesicular carriers is disrupted
[19, 23]. Similar to Dyn, other endocytic proteins may be
mislocated and may interact less eﬃciently aﬀecting the dy-
namic nature of endocytic complexes [23]. Thus, regardless
ofthemolecularmechanismsinvolved—impairedDynfunc-
tion, in the case of the SH3A expression, or ineﬃcient Dyn
recruitment to the endocytic site, in the case of ITSN-1s
knockdown—the membrane ﬁssion reaction is inhibited
and caveolae detachment from the plasma membrane does
not occur. ITSN-1s with its ﬁve SH3 domains is critical in
maintaining high Dyn concentration and thus, regulation of
its GTPase activity and oligomerization at the endocytic site.
Transendothelial transport (transcytosis) via caveolae is
the dominant mechanism of transendothelial transport; the
number of clathrin-coated vesicles in ECs is relatively small
andtheircontributiontotheinternalizationprocessisminor
[6, 42, 43]. In ECs the true caveolae (vesicular carriers Cav1
positive) represent ∼95% of the whole vesicular population
and the non-Cav1 and nonclathrin vesicles identiﬁed in the
Cav1 null mouse are poorly represented and not yet well
deﬁned as a Cav1 and clathrin-independent vesicular trans-
port system [44, 45]. Our studies conﬁrmed that indeed
caveolae are the main vesicular carriers of ECs functioning
in transendothelial transport. Similar to Cav1 null mice, that
lackmorphologicallyidentiﬁablecaveolae,alteredexpression
of ITSN-1s, by decreasing caveolae number and impairing
their transport function, activated compensatory transport
pathways. We showed here that increased paracellular trans-
port of tracer particles with diameter between 6nm (DNP-
BSA) to 20nm (Au-BSA) occurs in the ECs of mice with
acutemodulationofITSN-1slevels,whilethehighfrequency
ofpleomorphictubulovesicularandringlikestructureslabel-
ed by Au-BSA, implied their direct participation in tracer
uptake and cellular traﬃcking. ITSN-1s deﬁciency was able
not only to induce activation of classical interendothelial
pathway, but also to modulate the opening of the junctions.
Under conditions of ITSN-1s chronic inhibition, the par-
acellular pathway is still leaky but not permeable to 18nm
diameter tracer. Apparently, ECs deﬁcient of ITSN-1s limit
the activation of the paracellular pathway to small molecu-
les, while the transport of macromolecules (Au-BSA and
DNP-BSA) reach similar values as the controls. This appar-
ent return of junctional integrity may be part of a gen-
eral protective mechanism against inﬂammation and lung12 Biochemistry Research International
injury. Moreover, the increased presence of pleomorphic
tubulovesicular and ringlike structures labeled by Au-BSA
suggests their augmented participation in tracer uptake and
cellular traﬃcking. To our knowledge, this is the ﬁrst report
showing the in vivo modulation of alternative transport
pathways.
A large intracellular tubulovesicular network of endoso-
mal origin that extended all the way from the nucleus to the
plasma membrane and involved in receptor recycling has
been previously reported [46]. Later on, a similar system
was characterized by Palade’s group and shown to comprise
G-protein-coupled receptors for thrombin and platelet acti-
vating factor [33, 40, 47, 48]. Structurally, it was shown that
this tubulovesicular network does not colocalize with the
early endosomes, Golgi and endoplasmic reticulum. More-
over, the network was shown to communicate with both
extracellular environment and nuclear compartment of ECs.
HRP uptake studies indicated that HRP labeled this tubular
network, in just minutes of treatment, consistent with the
idea it participates very early in the internalization process
[33]. In the mouse models used in this study, the alternative
intracellular transport routes are upregulated; deﬁcient re-
cruitment and impaired Dyn function at the endocytic sites
due to SH3A expression or ITSN-1s depletion may favor the
formation of tubular structures as shown in cells with condi-
tional Dyn1/Dyn2 knockout [34]. In addition, an impaired
coordination between membrane invagination and vesicle
detachment may lead to formation of large invaginations.
Both ITSN-1s and 2 directly interact with the FCHo1/2 Bar
domain containing proteins [24, 49]. While no direct func-
tional link has been established between ITSN-1s and F-BAR
domain containing proteins in caveolae budding, this inter-
action is likely to account for the altered caveolae mor-
phology within the tubulovesicular structures and caveolae
clusters. Interestingly, chronic inhibition of ITSN-1s shows
no increase in the DNP-BSA transported to the interstitia.
Widening of IEJs is limited. The number of nonconventional
endocytic structures was greater, with the membranous ring/
tubules showing a 2-fold increase, compared to 72h ITSN-1s
knockdown.
While our results can be explained by a model where
ITSN-1s modiﬁed expression and Dyn2 impaired function
may favor membrane tubulation, a direct action of ITSN-1s
on actin polymerization cannot be ruled out. Wehave shown
that the temporal and spatial actin polymerization and re-
modeling subadjacent to the plasma membrane plays an
important role in caveolae internalization [50]. ITSN-1s
binds via its SH3A the N-WASp, [51], an actin-nucleating
factor that acts at the plasma membrane upstream of Arp2/3
complex [52]. The physiological signiﬁcance of WASp inter-
action with short ITSN-1, which does not possess the DH-
PH tandem as the long ITSN isoforms, is still not under-
stood. Impaired caveolae internalization and traﬃcking may
also have eﬀects on cellular signaling. The upregulation of
endocytic membranous structures may provide distinct sig-
naling platforms [53], capable of partially compensating for
caveolae signaling. Moreover, the caveolae number was par-
tially restored, suggesting that the highly homologous ITSN-
2s isoform may partially compensate for ITSN-1s chronic
deﬁciency, a question that remains to be addressed in future
work.
Caveolae and Cav1are involved in important cellular
f u n c t i o n ss u c ha sp r o l i f e r a t i o n ,a p o p t o s i s ,c e l ld i ﬀerentia-
tion, cell migration, endocytosis, and transcytosis [44, 54,
55]. Caveolae are present in all cell types in the lung, includ-
ing ECs, epithelial cells, smooth muscle cells, ﬁbroblasts,
telocytes, and macrophages [55, 56]. Recent research impli-
cated caveolae and Cav1 in pathogenesis of human lung
disease [45, 57, 58], neurodegenerative diseases [59], and
lungcancer[60,61].NotonlyCav1,butalsotheubiquitously
expressed ITSN-1s, a major protein of lung tissue, has been
related to lung inﬂammatory conditions [62], to endosomal
disorders associated with the earliest pathogenesis of Alz-
heimer’s disease and Parkinson’s diseases [63]a sw e l la sc a n -
cer [64, 65]. Thus, a better understanding of the endocytic
function of ITSN-1s and how it regulates caveolae internali-
zation and traﬃcking may provide new insights for under-
standing of human disease and give new opportunities for
novel targets in therapeutic approaches.
In conclusion, our results provide new information on
the in vivo role of ITSN-1s as a scaﬀold, recruiter and regu-
lator of caveolae endocytic machinery and strengthen the
evidence for a functional endocytic tubulovesicular network
induced by ITSN-1s deﬁciency.
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